메뉴 건너뛰기

(주)서호 KS Q ISO/IEC 17025 국제공인교정기관 제약분야전문교정기관

GMP관련자료

해외 각국 정부, 주요 언론이 발표한 안전 정책, 법령, 사건, 사고, 연구조사 결과 등 최신 정보를 제공합니다.
조회 수 1215 추천 수 0 댓글 0
?

단축키

Prev이전 문서

Next다음 문서

크게 작게 뷰어로 보기 위로 아래로 댓글로 가기 인쇄
?

단축키

Prev이전 문서

Next다음 문서

크게 작게 뷰어로 보기 위로 아래로 댓글로 가기 인쇄

<국내 제조소>
의약품 제조 및 품질관리기준(GMP)
정기약사감시 주요 보완사례(‘15~’17)(Ⅱ)
2017. 12.
의약품안전국 의약품관리과

 

목 차
1. 의약품 제조소(GMP) 정기감시 현황 ················· 4
2. 주요 지적사례
Ⅰ. 시설관리 ·············································································· 5
Ⅱ. 환경관리 ············································································ 6
Ⅲ. 조직 ···················································································· 7
Ⅳ. 기준서 ················································································ 8
Ⅴ. 문서 ···················································································· 9
Ⅵ. 밸리데이션 ········································································ 10
Ⅶ. 품질관리 ············································································ 11
Ⅷ. 제조관리 ············································································ 12
Ⅵ. 기타 ···················································································· 13

 

1 의약품 제조소(GMP) 정기감시 현황
Ⅰ. 감시 개요
식약처는 의약품 제조단계에서의 품질 위해 최소화를 위해 국내 모든
의약품 제조소를 대상으로 정기 현장감시를 실시하고 있습니다.
특히 2014년 7월 의약품실사상호협력기구(PIC/S) 가입으로 3년 유효
기간의 제조 및 품질관리기준(GMP) 적합판정서 발급을 위해 완제 및 원료
의약품 제조소에 대해서는 2015년부터 3년 주기의 정기감시와 GMP 적합
판정 평가를 연계하여 실시하고 있습니다.

 

www.seoho.biz

서호 전북 전주시 덕진구 혁신로 586 (54851)

Tel. 063-214-9325 / Fax. 063-214-9328

seoho@seoho.biz


List of Articles
번호 제목 최근 수정일 조회 수
공지 '의약품 제조업체 데이터 완전성 평가지침' 관련 행정지시 2022-03-23 file 2022.03.31 1039
공지 '의약품 제조업체 데이터 완전성(Data Integrity) 평가지침' 관련 행정지시 (2020.10.29)식품의약품안전처 1 file 2021.04.30 4307
공지 US FDA Office of Regulatory Affairs (ORA 품질 정책 사무국 (ORA) 품질 정책 연구소) Laboratory Manual of Quality Policies file 2021.04.08 1287
공지 PIC/S GUIDE PE 011-1 1 June 2014 CHAPTER 3 3.4 EQUIPMENT Calibration / alarm systems 2022.02.09 687
74 20170531_완제의약품 제조 및 품질관리기준(GMP) 가이던스(민원인 안내서)(제2개정) file 2018.09.21 1314
73 2020년도 GMP 정책설명회 및 QbD 워크숍 발표 자료 총리령 및 고시 주요 개정 사항 안내 file 2021.06.29 38793
72 2021년도 GMP 정책설명회 및 QbD 워크숍 발표자료 file 2022.07.06 100
71 21 Cfr Part 11에 대한 NewFDA 지침- »타임 스탬프« 2021.03.16 2137
70 CFR - Code of Federal Regulations Title 21CFR211 2018.08.07 2305
69 Data Integrity and Compliance with cGMP –Guidance for Industry FDA–April 2016 file 2018.08.07 4325
68 Data-Integrity-in-Pharmaceutical 2018.08.07 4916
67 EN285 온도 허용오차 제시 LOOP CALIBRATION 50 °C to 150 °C, 1% (6.2.1.3 d) 2021.07.02 2894
66 Food and Drug Administration (Table 2. Equipment Calibration or Verification Requirements ) file 2020.05.08 314
65 GAMP 5 Guide: Compliant GxP Computerized Systems 1 file 2021.09.01 36617
64 GAMP® Good Practice Guide: Supplier Selection file 2023.03.31 142
목록
Board Pagination Prev 1 2 3 4 5 6 Next
/ 6
위로